Northwest Biotherapeutics(DE:NBYB)
€0.15+0.00 (+3.57%)
DE:NBYB
Northwest Biotherapeutics stock drug pipeline
€0.15
At close:+0.00 (+3.57%)
Northwest Biotherapeutics (NBYB) Drug Pipeline
0 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Dcvax-Direct | Brain Metastases, Breast Cancer Metastatic, Lung Cancer Metastatic | Phase I | Unknown | Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer | Aug 15, 2018 | ― |
| Dcvax-Direct | Colorectal Cancer, Pancreatic Cancer, Melanoma, Locally Advanced Tumor, Metastatic Solid Tissue Tumors, Liver Cancer | phase1AndPhase2 | Unknown | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | Jun 14, 2013 | ― |
| Dendritic Cell Immunotherapy | Glioma, Glioblastoma, Brain Tumor, Gbm, Glioblastoma Multiforme, Grade Iv Astrocytoma, Brain Cancer | Phase III | Unknown | Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer | Sep 17, 2002 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Dcvax-Direct | Phase I | Brain Metastases, Breast Cancer Metastatic, Lung Cancer Metastatic | Unknown | Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer | Aug 15, 2018 | ― |
| Dcvax-Direct | phase1AndPhase2 | Colorectal Cancer, Pancreatic Cancer, Melanoma, Locally Advanced Tumor, Metastatic Solid Tissue Tumors, Liver Cancer | Unknown | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | Jun 14, 2013 | ― |
| Dendritic Cell Immunotherapy | Phase III | Glioma, Glioblastoma, Brain Tumor, Gbm, Glioblastoma Multiforme, Grade Iv Astrocytoma, Brain Cancer | Unknown | Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer | Sep 17, 2002 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Northwest Biotherapeutics (DE:NBYB) have in its pipeline
Northwest Biotherapeutics DE:NBYB is currently developing the following drugs: Dcvax-Direct, Dendritic Cell Immunotherapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
